Skip to main content
. 2017 Jul 31;8(48):83831–83844. doi: 10.18632/oncotarget.19747

Figure 4. MiR-340 inhibits motility of and the Warburg effect in breast cancer cells.

Figure 4

(A) Wound-healing (top, middle) and Transwell invasion (bottom) assays of MDA-MB-231 cells treated with an miR-340 mimic (mimics-340) or NC. (B) Glucose (Glu) uptake, ATP levels, LDH levels, and lactate production in MDA-MB-231 cells expressing mimics-340. (C) Wound-healing and Transwell invasion assays of MCF7 cells expressing inhibitor-340. (D) Glucose uptake, ATP levels, LDH levels, and lactate production in MCF7 cells expressing inhibitor-340. The error bars in all the bar graphs represent SD. Statistical significance was determined via one-way analysis of variance followed by pairwise t-tests.*P<0.05; **P< 0.01.